Embecta Corp Net Income Over Time
| EMBC Stock | USD 10.47 0.88 7.75% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Embecta Corp Performance and Embecta Corp Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could Embecta diversify its offerings? Factors like these will boost the valuation of Embecta Corp. Projected growth potential of Embecta fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Embecta Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.827 | Dividend Share 0.45 | Earnings Share 2.45 | Revenue Per Share | Quarterly Revenue Growth (0) |
Embecta Corp's market price often diverges from its book value, the accounting figure shown on Embecta's balance sheet. Smart investors calculate Embecta Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Embecta Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Embecta Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Embecta Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Embecta Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income Analysis
Compare Embecta Corp and related stocks such as CareDx Inc, SIGA Technologies, and Emergent Biosolutions Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDNA | (5.1 M) | (5.1 M) | (5.1 M) | (3.5 M) | 781 K | (13.7 M) | (39.5 M) | (55.5 M) | (46.8 M) | (22 M) | (18.7 M) | (30.7 M) | (76.6 M) | (190.3 M) | 52.5 M | 47.3 M | 49.7 M |
| SIGA | (2.3 M) | 13.6 M | (14.5 M) | (17.2 M) | (265.5 M) | (39.5 M) | (39.7 M) | (36.2 M) | 421.8 M | (7.2 M) | 56.3 M | 69.5 M | 33.9 M | 68.1 M | 59.2 M | 68.1 M | 71.5 M |
| EBS | (554 K) | 23 M | 23.5 M | 31.1 M | 36.7 M | 62.9 M | 51.8 M | 82.6 M | 62.7 M | 54.5 M | 305.8 M | 219.5 M | (223.8 M) | (760.5 M) | (190.6 M) | (171.5 M) | (163 M) |
| AQST | (8.3 M) | (9.6 M) | (9.6 M) | (9.6 M) | (9.6 M) | (9.6 M) | (9.6 M) | (8.9 M) | (61.4 M) | (66.2 M) | (55.8 M) | (70.5 M) | (54.4 M) | (7.9 M) | (44.1 M) | (39.7 M) | (41.7 M) |
| MYGN | (5.9 M) | 100.7 M | 112.2 M | 147.1 M | 176.2 M | 80.2 M | 125.3 M | 21.8 M | 131 M | 4.6 M | (223.7 M) | (27.2 M) | (112 M) | (263.3 M) | (127.3 M) | (114.6 M) | (108.8 M) |
| VIR | (69.9 M) | (69.9 M) | (69.9 M) | (69.9 M) | (69.9 M) | (69.9 M) | (69.9 M) | (69.9 M) | (115.9 M) | (174.7 M) | (298.7 M) | 528.6 M | 515.8 M | (615.1 M) | (522 M) | (469.8 M) | (446.3 M) |
| EVH | (19.3 M) | (19.3 M) | (19.3 M) | 20 M | (25.2 M) | 332.5 M | (159.7 M) | (60.7 M) | (52.7 M) | (302 M) | (334.2 M) | (37.6 M) | (19.2 M) | (113 M) | (61.6 M) | (55.5 M) | (58.2 M) |
| MRVI | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (8.5 M) | 76.9 M | 182 M | 220.2 M | (119 M) | (144.8 M) | (130.4 M) | (123.8 M) |
| PSNL | (23.6 M) | (23.6 M) | (23.6 M) | (23.6 M) | (23.6 M) | (23.6 M) | (23.6 M) | (23.6 M) | (19.9 M) | (25.1 M) | (41.3 M) | (65.2 M) | (113.3 M) | (108.3 M) | (81.3 M) | (73.2 M) | (76.8 M) |
Embecta Corp and related stocks such as CareDx Inc, SIGA Technologies, and Emergent Biosolutions Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Embecta Corp financial statement analysis. It represents the amount of money remaining after all of Embecta Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Embecta Corp | EMBC |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 300 Kimball Drive, |
| Exchange | NASDAQ Exchange |
USD 10.47
Check out Embecta Corp Performance and Embecta Corp Correlation. For information on how to trade Embecta Stock refer to our How to Trade Embecta Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Embecta Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.